Corvus Pharmaceuticals, Inc. (CRVS) total assets

Total assets · fiscal 2025
$71.12M

Corvus Pharmaceuticals, Inc. (CRVS) had total assets of $71.12M at the end of fiscal 2025 (December 31, 2025). That is 3.2% higher than the $68.91M of fiscal 2024. Figures as of 18 Nov 2026, 10:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$71.12M
Change on fiscal 2024
+3.2%
Growth, 5 years
−3.6% a year
Growth, 10 years
−3.2% a year
Highest on record
$140.15Mfiscal 2016
Lowest on record
$45.55Mfiscal 2023
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corvus Pharmaceuticals, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 3.6% a year; over ten years the rate was −3.2% a year. Across the 11 fiscal years on record (2015–2025), the highest was $140.15M in fiscal 2016 and the lowest $45.55M in fiscal 2023.

History · 11 fiscal years

Total assets by fiscal year

Corvus Pharmaceuticals, Inc. total assets, year by year

Corvus Pharmaceuticals, Inc. (CRVS) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$71.12M 3.2% up
2024$68.91M 51.3% up
2023$45.55M 33.2% down
2022$68.24M 37.7% down
2021$109.46M 28.0% up
2020$85.53M 2.3% up
2019$83.65M 29.3% down
2018$118.23M 24.8% up
2017$94.78M 32.4% down
2016$140.15M 42.3% up
2015$98.46M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on CRVS

Corvus Pharmaceuticals, Inc., figure by figure

Corvus Pharmaceuticals, Inc. (CRVS) overview: price, valuation and scorecard

Corvus Pharmaceuticals, Inc. total assets: questions and answers

How large are Corvus Pharmaceuticals, Inc.'s total assets?

Corvus Pharmaceuticals, Inc. (CRVS) had total assets of $71.12M at the end of fiscal 2025 (December 31, 2025). That is 3.2% higher than the $68.91M of fiscal 2024.

What is the growth rate of Corvus Pharmaceuticals, Inc.'s total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 3.6% a year; over ten years the rate was −3.2% a year.

What are the highest and lowest total assets figures on record for Corvus Pharmaceuticals, Inc.?

Across the 11 fiscal years on record (2015–2025), the highest was $140.15M in fiscal 2016 and the lowest $45.55M in fiscal 2023.

How is Corvus Pharmaceuticals, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Corvus Pharmaceuticals, Inc. it is on record here for 11 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corvus Pharmaceuticals, Inc. (CRVS) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/CRVS/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.